Category - Pharma Industry News
Pfizer/BioNTech receives expanded authorisation from the FDA for its COVID-19 booster
2021 headlines: Pharma’s top five stumbles, spectacles and controversies
Special Report: Efficiency gains for pharmaceutical QC
Special Report: Pharma automation and control
Special Report: Advancing pharma 4.0 with data fabric
Novartis to pay up to $1.5bn for Gyroscope
FDA rejects Takeda’s Eohilia after delays
AstraZeneca and Novavax say their vaccines are effective against Omicron